Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_17_библиотеки_им_акад_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
66 Мб
Скачать
20
https://t.me/medicina_free
B. J. Levens et al.
ambulation. The research on this, however, is conict­ing. Several observational studies show symptomatic relief and decrease in lateral thrust of the knee with lat-
2
eral wedged insoles. However, in several RCTs, there was no improvement in pain scores or functional outcomes at 6months or 2years follow-up (Maillefert etal. 2001; Pham et al. 2004). Other therapeutic options such as thermal modalities, transcutaneous electrical nerve stimulation (TENS), and acupuncture are all weakly recommended by the OARSI and lack strong consensus among the existing guidelines. Unlike the OARSI, the AAOS recommends strongly against acupuncture ther­apy (Scuderi and Insall 1992; Zhang etal. 2008).
The OARSI recommends a multimodal approach of both pharmacological and non-pharmacological options in treating OA.Pharmacologically, the OARSI recommends the use of acetaminophen or paracetamol for the treatment of mild to moderate pain in OA.The previously recommended dose of up to 4g/day has more recently come into question. The risk of gastrointestinal (GI) and renal toxicity with long-term use of acetamin­ophen 4 g/day has been equivocal (Garcia Roderiguez and Hernandez-Diaz 2001). For this reason, short-term use is preferred.
As mentioned previously, damaged cartilage produces an inammatory response in the knee joint via the release of cytokines. These cytokines (interleukin-1B, interleukin- 6, and tumor necrosis factor alpha) bind to cellular receptors activating intracellular signaling path­ways such as mitogen-activated protein kinase (MAPK), nuclear factor kappa-B (NF-kB), and Janus kinase­signal transducer and activator of transcription (JAK STAT). The activation of these pathways triggers the production of arachidonic acid via phospholipase A2. Arachidonic acid is further broken down by cyclo­oxygenase (COX) enzymes into signaling molecules prostaglandin, leukotriene, and thromboxane, which are responsible for the transmission of pain. Corticosteroids bind to glucocorticoid receptors in the cell- inhibiting activation of intracellular signaling cascade. By repress­ing NF-kB, MAPK, and JAK STAT, further propaga­tion of inammatory response is prevented. Corticosteroids also inhibit phospholipase A2 which results in decreased production of signaling molecules prostaglandin, leukotriene, and thromboxane. Therefore, through repression of inammatory cascade, corticoste­roids, in theory, reduce pain (Lawrence
2009; Chen etal.
2018). OARSI recommends the use of corticosteroid
injections with moderate strength of recommendation.
> Analogously, non-steroidal anti-inammatory drugs
(NSAIDs) are also strongly recommended by both
the OARSI and AAOS, but only for short-term use
due to the risk of GI discomfort. Opioids are strongly
recommended only for the management of severe
pain in exceptional circumstances (Scuderi and Insall
1992; Zhang etal. 2008).
Due to inconclusive research, the AAOS cannot recom­mend for or against the use of corticosteroid injections. Based on a 2015 Cochrane review, corticosteroid injec­tions were shown to provide a moderate short- term improvement in pain and only small improvement in function. These results, however, were inconclusive due to small effect size and large degree of heterogeneity
among studies (Jüni etal. 2015). Oral supplementation is another modality that can be used in the treatment of osteoarthritis, albeit with variable results and limited recommendations. The most common supplements are glucosamine and chondroitin, which are components of cartilage. Proponents of these compounds as supplements purport that they stimulate synovial uid production and improve cartilage healing (Lim etal. 2019). When reviewed in 2005 by Cochrane, pooled analysis of multiple RCTs found improvement in pain and function, however, there was considerable heterogeneity among the studies resulting in questionable outcomes. For this reason, the OARSI only weakly recommends the use of glucos­amine and/or chondroitin for symptomatic treatment of knee OA.The AAOS strongly recommends against glucos­amine based on lack of effectiveness (Scuderi and Insall
1992; Zhang etal. 2008).
Corticosteroid intra-articular injections are a com­monly used noninvasive treatment modality in most orthopedic surgery practices. First tested in a clinical trial by Miller in 1958, corticosteroids have been used for knee OA for over 50 years (Miller et al. 1958). Corticosteroids have a strong anti-inammatory effect.
Viscosupplementation is another type of intra­articular injection which attempts to restore natural ele­ments to a depleted arthritic knee. The most common viscosupplement is hyaluronic acid (HA), a glycosami­noglycan. Hyaluronic acid is the main component of synovial uid and acts as a lubricant and shock absorber in the joint providing a chondroprotective effect. Despite the theoretical utility, research on viscosupple­mentation has been largely inconclusive. In a recent meta-analysis by Jevsevar etal. of only double-blinded RCTs with over 60 patients, there was no clinically sig­nicant difference between HA and placebo. However, when all literature in the analysis was included, the HA treatment group was slightly higher than placebo (Jevsevar etal. 2015). The OARSI found that although HA has a delayed onset when compared with cortico­steroids, it may have a prolonged duration. The strength of this recommendation, however, is weak. Unlike the OARSI, the AAOS strongly recommends against the use of viscosupplementation for the conservative treat­ment of OA (Scuderi and Insall 1992; Zhang et al.
2008).
Osteoarthritis
https://t.me/medicina_free
21
2
2.5.2 Surgical Intervention: Cemented
Total Knee Arthroplasty
When conservative treatment has failed and the patient continues to have pain, stiffness, limited mobility, and/or decreased quality of life, surgical management should be considered. Several surgical options are available for the management of OA with varying degrees of success. For the purpose of this chapter, we will only be discuss­ing cemented total knee arthroplasty (TKA) as a treat­ment for OA of the knee.
Total knee replacement is the most commonly per­formed operation amongst orthopedic surgeons. More than 600,000 knee replacements are performed each year in the United States. Primary TKA is projected to increase by 637% by 2030in the United States (OKU Hip and Knee 5 2017). The primary indication for TKA is OA, which accounts for more than 94% of total pro­cedures (Van Manen etal. 2012).
> In terms of TKA technique, cemented arthroplasty
remains the gold standard.
Scuderi and Insall describe the technique of xation of the cement, methylmethacrylate, to the bone surface. Fixation is achieved by the irregular conguration of the bony surface and cement penetration into the micro­structure of the cancellous bone. Prior to cementation, pulsatile lavage assists in the removal of debris from the bony indices allowing for adequate penetration of cement (Scuderi and Insall 1992).
More recently, cementless TKA has emerged as another surgical option, but further research is required to comment on long-term durability. Cemented TKA provides the surgeon with optimal outcomes without relying on anatomic cuts and supplemental xation, which is required to achieve adequate bony ingrowth in cementless xation (Callaghan and Liu 2010). The imme­diate xation from cement allows for immediate, unre­stricted weight-bearing and the ability to start rehabilitation more rapidly. Although cementless TKA was initially developed to benet younger patients, when compared to cemented TKA in patients 60years and less, both groups were found to have similar functional out­comes and survival rates (Franceschetti etal. 2017; Behery et al. 2017). Cemented TKA has consistently demon­strated long-term success in multiple different survivor­ship studies. Scuderi and Insall found their 15-year success rate to be around 91% in 1992. More recent studies have shown the survivorship to be 97% at 10 and 12 years (Falatyn et al. 1995; Ranawat et al. 1993). These long­term studies further emphasize the success of cemented TKA as an ideal surgical treatment of OA.
2.6 Conclusion
Osteoarthritis affects millions of patients with a multifac­torial genesis. Nonoperative treatment includes weight loss, physical therapy, NSAIDs, and intra- articular injec­tions. When nonoperative treatment is no longer effective, surgical management with cemented TKA is a viable treat­ment option with proven long-term results.
Take-Home Messages
5 Osteoarthritis is a common source of knee pain and
can cause a great degree of disability.
5 The pathophysiology of osteoarthritis involves
cyclical cartilage damage predominantly due to cat­abolic enzymes secreted by chondrocytes and syno­vial macrophages.
5 The radiographic signs of osteoarthritis include
joint space narrowing, subchondral bone sclerosis, osteophyte formation, and cystic changes. Although present in many elderly patients, these ndings may be asymptomatic.
5 The clinical signs of osteoarthritis are knee pain
with weight-bearing activities, morning stiffness lasting less than 30 minutes, decreased range of motion, and crepitus.
5 Conservative treatment is recommended for at least
6months prior to surgical intervention for osteoar­thritis. The best conservative therapy involves a combination of pharmacologic and non­pharmacologic modalities.
5 Weight loss, low impact exercise, physical therapy,
and walking aids are all strongly recommended by either the AAOS and/or OARSI. NSAIDs, acet­aminophen, and tramadol are also strongly recom­mended pharmacologically.
5 Although frequently used in practice, the research
behind intra-articular injections such as corticoste­roids and HA is equivocal and therefore based on only weak to moderate recommendation.
5 When conservative treatment measures have been
exhausted, total knee arthroplasty is an ideal surgi­cal treatment for symptomatic relief.
5 Cemented TKA remains the gold standard for treat-
ment with excellent long-term survivorship.
References
Behery OA, Kearns SM, Rabinowitz JM, Levine BR (2017)
Cementless vs cemented Tibial xation in primary total knee arthroplasty. J Arthroplast 32(5):1510–1515
Bijlsma JW, Berenbaum F, Lafeber FP (2011) Osteoarthritis: an
update with relevance for clinical practice. Lancet 377(9783):2115–2126
22
https://t.me/medicina_free
B. J. Levens et al.
Blagojevic M, Jinks C, Jeffery A, Jordan KP (2010) Risk factors for
onset of osteoarthritis of the knee in older adults: a systematic
review and meta-analysis. Osteoarthr Cartil 18(1):24–33 Brown GA (2013) AAOS clinical practice guideline: treatment of
2
osteoarthritis of the knee: evidence-based guideline, 2nd edition.
J Am Acad Orthop Surg 21(9):577–579 Callaghan JJ, Liu SS (2010) Cementless tibial xation in TKA: not a
second coming. Orthopedics 33(9):655 Chen D, Shen J, Zhao W etal (2017) Osteoarthritis: toward a com-
prehensive understanding of pathological mechanism. Bone Res
5:16044 Chen L, Deng H, Cui H et al (2018) Inammatory responses and
inammation-associated diseases in organs. Oncotarget
9(6):7204–7218 Falatyn S, Lachiewicz PF, Wilson FC (1995) Survivorship analysis of
cemented total condylar knee arthroplasty. Clin Orthop Relat
Res 317:178–184 Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan
RF (1987) The prevalence of knee osteoarthritis in the elderly:
the Framingham Osteoarthritis Study. Arthritis Rheum
30(8):914–918 Franceschetti E, Torre G, Palumbo A et al (2017) No difference
between cemented and cementless total knee arthroplasty in
young patients: a review of the evidence. Knee Surg Sports
Traumatol Arthrosc 25(6):1749–1756 Garcia Roderiguez LA, Hernandez-Diaz S (2001) Risk of upper gas-
trointestinal complications among users of acetaminophen and
non-steroidalantiinammatory drugs. Epidemiology 12:570e6 Goldring MB (2000) The role of the chondrocyte in osteoarthritis.
Arthritis Rheum 43(9):1916–1926 Jevsevar D, Donnelly P, Brown GA, Cummins DS (2015)
Viscosupplementation for osteoarthritis of the knee: a system-
atic review of the evidence. J Bone Joint Surg Am 97(24):2047–
2060 Jüni P et al (2015) Intra-articular corticosteroid for knee osteoarthri-
tis. Cochrane Database Syst Rev. https://doi.
org/10.1002/14651858. cd005328.pub3
Lawrence T (2009) The nuclear factor NF-kappaB pathway in
inammation. Cold Spring Harb Perspect Biol 1(6):a001651 Lim YZ etal (2019) Nutrients and dietary supplements for osteoar-
thritis. In: Bioactive food as dietary interventions for arthritis
and related inammatory diseases, 2nd edn. Academic Press.
https://www. sciencedirect. com/science/article/pii/ B9780128138205000064
Maillefert JF, Hudry C, Baron G, Kieffert P, Bourgeois P, Lechevalier
D etal (2001) Laterally elevated wedged insoles in the treatment of medial knee osteoarthritis: a prospective randomized con­trolled study. Osteoarthr Cartil 9:738e45
Miller JH, White J, Norton TH (1958) The value of intra-articular
injections in osteoarthritis of the knee. J Bone Joint Surg Br Vol 40-B(4):636–643
Musculoskeletal Conditions (2019) World Health Organization,
World Health Organization. https://www.who.int/news-room/
factsheets/detail/musculoskeletal-conditions
Nguyen UA, Zhang Y, Zhu Y, Niu J, Zhang B, Felson DT (2011)
Increasing prevalence of knee pain and symptomatic knee osteo­arthritis: survey and cohort data. Ann Intern Med 155(11):725– 732
Old AB, Long WJ, Scott WN (2017) Chapter 11: Special
Considerations in Primary Total Knee Arthroplasty. OKU Hip & Knee 5
Pham T, Maillefert JF, Hudry C, Kieffert P, Bourgeois P, Lechevalier
D etal (2004) Laterally elevated wedged insoles in the treatment of medial knee osteoarthritis. A two-year prospective random­ized controlled study. Osteoarthr Cartil 12:46e55
Ranawat CS, Flynn WF, Saddler S, Hansraj KK, Maynard MJ
(1993) Long-term results of the total condylar knee arthro­plasty. A 15-year survivorship study. Clin Orthop Relat Res 286:94–102
Scuderi GR, Insall JN (1992) Total knee arthroplasty. Current clini-
cal perspectives. Clin Orthop Relat Res 276:26–32
Sellam J, Berenbaum F (2010) The role of synovitis in osteoarthritis.
Nat Rev Rheumatol 6:625–635
Van Manen MD, Nace J, Mont MA (2012) Management of primary
knee osteoarthritis and indications for total knee arthroplasty for general practitioners. J Am Osteopath Assoc 112(11):709– 715
Zhang W, Moskowitz RW, Nuki G etal (2008) OARSI recommenda-
tions for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartil 16(2):137–162
Osteoarthritis andOther
https://t.me/medicina_free
Indications forTotal Knee Arthroplasty: AnEast African Perspective
SeidMohammedYasin
Contents
3.1 Osteoarthritis – 24
3.1.1 Introduction – 24
3.1.2 Risk Factors – 24
3.1.3 Pathology – 25
3.1.4 Clinical Features – 25
3.1.5 Laboratory Findings – 25
3.1.6 Radiologic Features – 25
3.1.7 Management – 25
3.1.8
Indications forTotal Knee Arthroplasty – 26
23
3
3.2 Total Knee Arthroplasty inEast (and Sub-Saharan) Africa – 30
References – 31
© The Author(s), under exclusive license to Springer-Verlag GmbH, DE, part of Springer Nature 2022 E. Hansen, K.-D. Kühn (eds.), Essentials of Cemented Knee Arthroplasty,
https://doi.org/10.1007/978-3-662-63113-3_3
24
https://t.me/medicina_free
S. M. Yasin
3.1 Osteoarthritis
5 Repetitive stress on a joint (e.g., frequent kneeling
3.1.1 Introduction
> Osteoarthritis (OA) is a disease characterized by
3
degeneration of cartilage and its underlying bone within a joint. It has traditionally been subdivided into either primary (idiopathic) or secondary forms considering its etiology.
and prolonged squatting)
5 Decreased bone density 5 Knee malalignment 5 Muscle weakness 5 Meniscal injuries 5 Other arthritic conditions 5 Joint laxity
Primary osteoarthritis is the most common type of arthritis and one of the commonest reasons for disabil­ity worldwide (Kim etal. 2011). It has been estimated that ~7.5% of people over 55 years of age have some knee pain and disability and that ~2% have severe prob­lems. Radiographic evidence of OA occurs in the major­ity of people of 65 years of age and in about 80% of those aged over 75 years (Arden and Nevitt 2006). About 13% of women and 10% of men aged 60years and older have symptomatic knee OA (Zhang and Jor­dan 2010).
> OA of the knee is more prevalent and more severe in
women, especially after the age of 55years, as com­pared to males.
The prevalence of OA in Africa has not been investi­gated much. One such study showed that in rural Nige­ria, for instance, 1 out of every 5 adults aged 40 have symptomatic knee OA (Akinpelu etal. 2011), indicating that the condition is quite rampant in the region.
OA of the knee is particularly important not only for its high prevalence rate compared with other types of OA but also for its presentation at an earlier age and its ongoing increase in incidence in line with the prevalence of aging and obesity.
Total knee arthroplasty (TKA), when indicated, is a very effective way of managing advanced OA as it improves quality of life through improving function and alleviation of pain (Katchy etal. 2018).
3.1.2 Risk Factors
OA is multifactorial and develops through a complex interplay of constitutional and mechanical factors.
Genetic predisposition has been blamed to contribute to the development of primary knee OA.In both genders, knee OA within parents, brothers, or sisters was a sig­nicant predictor for symptomatic knee OA in the inves­tigated person (Klussmann etal. 2010).
Aging is known to be an established risk factor for OA.The strong association between age and osteoar­thritis may best be explained by age-related changes in the matrix composition and a decrease in chondrocyte function as well as increased responsiveness to stimuli. These changes can interfere with continued internal remodeling, maintenance of the tissue, and loss of carti­lage (Hinton etal. 2002).
Obesity, on the other hand, is generally taken as a major risk factor for the occurrence of symptomatic knee OA.This correlation has been supported by numer­ous publications.
5 It has been shown that every 5kg of weight gain
results in a 36% increase in the risk of knee OA.
5 On the other hand, another study has reported that
5.1 kg weight reduction over a 10-year period
decreased the likelihood of women developing symp-
tomatic knee OA by 50%, revealing the presence of a
strong correlation between obesity and OA (Bliddal
etal. 2014).
> The pathogenetic role of obesity has been identied
to be beyond just a mechanical load on prone joints,
in that excess adipose tissue produces humoral fac-
tors, altering articular cartilage metabolism. The
leptin system has also been postulated to be the link
between OA and obesity. These premises may explain
the observed prevalence of OA in non-weight-bearing
joints such as hand joints of obese subjects (Heidari
2011).
Risk Factors for OA of the Knee with Dierent Degrees of Contributions
5 Genetic predisposition 5 Old age 5 Female sex 5 Overweight and obesity 5 Knee injury
Niu etal. (2009) examined the effect of obesity on knee OA and came up with the following conclusion: Obesity increases the incidence of OA but its contribution to the progression of an already established knee OA may not be as signicant. However, this conclusion has so far been an area of debate in the literature.
Occupations that involve knee-straining work activi­ties such as excessive kneeling and squatting or lifting and
Osteoarthritis andOther Indications forTotal Knee Arthroplasty: AnEast African Perspective
https://t.me/medicina_free
25
3
carrying loads were found to be associated with symptomatic knee osteoarthritis (Klussmann et al.
2010).
> Other important risk factors include asymmetric
mechanical loading, infectious and noninfectious arthritic conditions as well as presence of meniscal injuries.
Regarding sports activities, there are conicting conclu­sions among different literatures, some of them regard­ing sports as risk factors, some others considering them protective against OA, while the rest regarding them as having no effect. In general, evidence show that heavy and repetitive sports could pose some risk of OA whereas moderate exercises are chondroprotective.
The lifetime risk of developing symptomatic knee OA (i.e., developing the condition by age 85 years) is estimated to be 44.7%, irrespective of sex, race, and level of education. The risk increased in the presence of his­tory of trauma and raised BMI/ obesity (Murphy etal.
2008).
3.1.3 Pathology
> The central pathologic features of OA are the loss of
hyaline articular cartilage and changes in the sub-
chondral bone.
The pathogenesis is directly linked to an increase in water content of the articular cartilage with a decrease in proteoglycan content. Collagenase levels increase, thereby disrupting maintained collagen. Proteolytic enzymes and inammatory cytokines, on the other hand, will increase and end up in an arthritic, painful joint (Martin etal. 2011).
Pathophysiology of the arthritic knee is also known to be related to changes in the autonomic nervous sys­tem, blood and lymph ow, fascial tension, limitations in range of motion, and relationships of the length and tension of the muscles around the knee (Van Manen etal. 2012).
descending stairs, palpable effusion, xed-exion defor­mity, restricted-exion range of motion, and crepitus predicted knee OA at sensitivity of 94% and specicity of 93%.
3.1.5 Laboratory Findings
> Complete blood count (CBC), erythrocyte sedimenta-
tion rate (ESR), and C-reactive protein (CRP) levels in OA are usually normal.
Synovial uid is of noninammatory type. In suspected cases of knee OA, synovial uid level of anti-CCP can be used for the differentiation of OA from RA (Heidari etal. 2010).
3.1.6 Radiologic Features
Radiologic appearance of an osteoarthritic knee exhib­its attestations for progressive destruction of the articu­lar cartilage like joint space narrowing and reparative processes such as osteophyte formation and subchon­dral sclerosis.
Subchondral cysts, though taken as one of the cardi­nal radiological features of OA, are absent in most patients with established OA.Audrey etal. (2014) have documented that subchondral cysts were only present in
30.6% of their study population while narrowed joint space, osteophytes, and subchondral sclerosis were found to be present in 99.5%, 98.1%, and 88.3% of all radiographs in their series, respectively.
Radiologic features are also used for the classica­tion of OA in an attempt to give an idea of severity of the arthritic process and joint degeneration. Kellgren and Lawrence in 1957 came up with a radiologic classi­cation of OA, which has later been endorsed by the WHO and continued to be one of the most accepted radiologic classications of OA to date (. Table 3.1;
. Figs.3.1, 3.2, and 3.3).
3.1.7 Management
3.1.4 Clinical Features
Common symptoms and signs of knee OA include per­sistent pain, reduced function, crepitus, and swelling. The swelling could result from effusion or could even be secondary to bony enlargement in late presentations.
According to Peat et al. (2007), together with expected demographic features such as age, sex, and body mass index, absence of whole leg pain, difculty in
In obese patients with primary OA of the knee, weight loss is the most important strategy to relieve symptoms, including pain, and to check disease progression through breaking the vicious cycle of events: reduced activity (because of pain and heavyweight), further weight gain, and decreased muscle strength, leading to further articu­lar damage.
A study on overweight and obese older adults with
knee OA estimated that every pound of lost weight
26
S. M. Yasin
https://t.me/medicina_free
. Table 3.1 Radiologic grading of OA (adapted from
Kellgren and Lawrence 1957)
Grade Radiologic ndings
0 No radiological ndings of osteoarthritis
3
I Doubtful joint space narrowing and possible
osteophytic lipping
II Denite osteophytes and possible joint space
narrowing
III Moderate multiple osteophytes, denite narrowing of
joint space, small pseudocystic areas with sclerotic walls, and possible deformity of bone contour
IV Large osteophytes, marked joint space narrowing,
severe sclerosis, and denite deformity of bone contour
Intra-articular corticosteroid injections, on the other hand, reduce knee pain for at least 1 week. They are taken as short-term management options for chronic osteoarthritic conditions (Hepper etal. 2009).
> Hyaluronic acid (HA) injections have a longer term
effect in pain control compared with corticosteroids
(Bellamy etal. 2006).
The use of glucosamine and chondroitin sulfate for symptomatic knee OA has not been supported by most publications despite the ongoing controversy regarding their patient-reported benets. All meta­analyses showed that the overall effect of these agents compared to placebo was not statistically signicant.
3.1.8 Indications forTotal Knee
Arthroplasty
resulted in a fourfold reduction in the load exerted on the knee per step during daily activities, which appears to be clinically meaningful (Bliddal etal. 2014).
The AAOS recommends self-management, exercise, and integrated healthcare programs for patients with knee OA.
> Professionally guided weight loss programs should be
incorporated including diet modication and specic
exercise programs which do not cause further stress
on the knee and its overlying cartilage.
The Framingham knee osteoarthritis study showed a greater than 50% reduction in primary knee OA with a decrease in body mass index of 2 or more (Felson etal.
1987).
Aquatic exercise, gait aids, cognitive behavioral ther­apy with an exercise component, and self-management programs were the recommended non-pharmacologic options. Moreover, for the rst time, mind–body exer­cises (Tai Chi and Yoga) have recently been recommended as core treatment options for individuals with knee OA.
Topical non-steroidal anti-inammatory drugs (NSAIDs) were strongly recommended for use in knee OA patients with no comorbidities. High-quality evi­dence involving a large number of patients showed mod­est benets over the course of 12 weeks (Bannuru etal.
2019).
As an initial drug treatment plan, a trial of acet­aminophen with other non-pharmaceutical treatments has been recommended before adding NSAIDs, consid­ering the overall cost of NSAIDs and their side effects (Wegman etal. 2004). However, AAOS does not recom­mend acetaminophen anymore claiming to have found no benets for it compared to placebo.
> Common diseases that cause knee damage requiring
arthroplasty are osteoarthritis, chronic rheumatoid arthritis, and osteonecrosis, while contraindications for knee arthroplasty include purulent arthritis and tuberculosis (Tateishi 2001).
Osteoarthritis, as an indication for surgery, is respon­sible for majority of TKAs done worldwide. In the USA, one population-based study identied OA to have accounted for 94%–97% of TKA operations (Singh etal. 2010). A search for a similar study in East African countries resulted in almost no data to be mentioned. The only paper identied was from Kenya, by Kigera and Kimpiatu (2015), which showed that
osteoarthritis was the indication for surgery in 96% of TKAs in their series. Other African countries like Nige-
ria and Malawi have studies that reported that OA accounted for 100% and 99% of the indications for TKA, respectively (Davies et al. 2019; Katchy etal.
2018).
Knee deformities can be taken both as predisposing
conditions for OA and consequences of OA marking severity of the condition and hence necessitating TKA. Analysis of 68 consecutive TKAs performed in Nigeria showed that 26.47% of replaced knees had val­gus before surgery, with a mean angle of 22.07°±5.73°, whereas 17.65% had varus knees with a mean angle of
14.69° ± 2.84°, and 11.77% knees were found to have
exion deformities with a mean angle of 10.2°±1.32°. The rest of 44.11% knees had no deformities (Katchy etal. 2018).
In the presence of radiologic evidence for end-stage
degenerative knee joint disease, Osteoarthritis Research Society International (OARSI) recommends TKA for OA when there is a continued pain despite an attempt of
Osteoarthritis andOther Indications forTotal Knee Arthroplasty: AnEast African Perspective
https://t.me/medicina_free
a
27
3
b
. Fig. 3.1 a, b Mild OA in a 62-year-old Ethiopian woman (Kellgren stage I)
a 6-month course of nonoperative treatment (Zhang etal. 2008). Besides, the decision to pursue TKA should
put the age and body habitus of the patient into consider­ation, since the outcome has been variable when TKA
was performed for younger and obese individuals in dif­ferent literatures. This guideline is also applicable for other degenerative joint diseases.
According to Hardorn and Holmes (1997), follow-
up of indications for TKA surgeries shows that patients below the age of 60 are less likely to be considered for a TKA and most surgeons want their obese patients to lose weight before surgery.
An additional factor identied to be among determi-
nants of considering candidates for surgery, as several
28
https://t.me/medicina_free
S. M. Yasin
3
. Fig. 3.2 Moderately advanced OA in a 67-year-old Ethiopian man (Kellgren stage II)
studies (summarized by O’Connor and Hooten 2011) have documented, is the presence of an unconscious bias on provider recommendations of TKA for male patients with moderate OA as compared to females with similar conditions.
Despite the numerous researches on the subject and several trials to come up with specic indications for TKA in patients with advanced knee OA, yet there is no consensus on when exactly to do TKA in the disease progress.
However, in the literature review performed by Dieppe et al. (1999), it was concluded that despite the lack of evidence-based indications for TKA in knee OA, daily pain and an attendant X-ray evidence of loss of joint space are taken as key indications for TKA in a consensus-style approach. A high patient motivation was also cited as a common factor contributing to the deci­sion to go ahead with surgery, whereas co- morbidities and technical difculties were common factors against it.
X-ray features can assist decision-making when both operative and nonoperative options are on the table for a particular patient. But it is wise to note that radio-
graphic appearance of the diseased knee may not always correlate with the degree of pain and disability the patient complains of. It is not uncommon to see patients with comparably affected bilateral knee X-rays, while symptoms are asymmetrical.
McAlindon etal. (1993) have been able to show that radiographic score does not make signicant indepen­dent contribution to prediction of disability. Quadriceps weakness has rather been found to be the most impor­tant factor, signaling the need for a thorough patient evaluation and exhaustion of nonoperative options before coming to a conclusion that TKA is the solution.
The Knee Osteoarthritis Grading System (KOGS) is a radiological grading system of degenerative arthritis of the knee. It is relatively easier to use and has the abil­ity to evaluate all three compartments of the knee to aid the surgeon’s decision on the type and timing of knee arthroplasty. Oosthuizen et al. (2018) have regarded KOGS as the rst and valid tri-compartmental grading system that can help in decision-making regarding the type and timing of knee arthroplasties based on the pre­operative OA status.
Osteoarthritis andOther Indications forTotal Knee Arthroplasty: AnEast African Perspective
https://t.me/medicina_free
29
3
. Fig. 3.3 Advanced OA in a 72-year-old Ethiopian woman (Kellgren stage III)
The Delphi consensus technique used by Hardorn and Holmes (1997), trying to derive surgical priorities in knee and hip replacement surgeries using clinical param­eters can also be taken as an assistive guide while mak­ing decisions (.
Table3.2).
Even though this technique, also referred to as “New Zealand priority criteria,” has been in use for several years in different institutions, its ability to accurately determine those patients who are most in need of joint replacement surgery has been questioned by Coleman etal. (2005) after comparing it with other scoring sys­tems for disability from musculoskeletal diseases such as the Western Ontario and McMasters Universities Arthritis Index (WOMAC) and the Musculoskeletal Function Assessment (MFA). Its use, hence, should be assisted with other radiologic parameters like KOGS to minimize subjectivity in decision-making.
. Table 3.2 Summary of New Zealand priority criteria for
major joint replacement
Pain (40%) Pain severity scored 0–20
Functional activity (20%)
Movement and deformity (20%)
Other factors (20%)
a
Patients are scored from 0 to 100 on a scale that describes different levels of severity in four domains: pain, function, joint damage and other factors
a
Pain occurrence scored 0–20
Walking difculty 0–10
Other functional impairment 0–10
Pain on active/passive motion 0–10
Other abnormalities including loss of movement and radiographic change 0–10
Other joints affected 0–10
Ability to work, act as a caregiver, and live independently 0–10
Соседние файлы в папке Библиотека им академика М.И. Перельмана